Skip to main content
. 2016 Nov 14;7:500. doi: 10.3389/fimmu.2016.00500

Figure 3.

Figure 3

Principle approach of adoptive T cell therapy for treatment of viral infections. Out of peripheral blood of the HSCT donor the virus-specific T cells are selected. The generated T cell product is infused into the patient suffering of viral complications after allogenic HSCT.